Search Orphan Drug Designations and Approvals
-
Generic Name: | N-[4-(3-amino1H-indazol-4-yl)phenyl]-N1-(2-fluoro-5-methylphenyl)urea |
---|---|
Date Designated: | 05/23/2007 |
Orphan Designation: | Treatment of hepatocellular carcinoma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 08/16/2014 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
AbbVie, Inc. 1 N. Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-